Table 2.
Comparison of renal variables between survivors and non-survivors
| Variable | Survivors (mean ± SD) | Non-survivors (mean ± SD) | P-value |
|---|---|---|---|
| Baseline creatinine (mg/dL) | 1.8 ± 0.5 | 1.7 ± 0.4 | 0.85 |
| Baseline estimated GFR (mL/min/1.73 m2) | 44.2 ± 14.6 | 41.7 ± 15.0 | 0.64 |
| CKD stage | 2.9 ± 0.6 | 3.0 ± 0.5 | 0.88 |
| Home loop dose (mg of oral furosemide equivalent) | 221 ± 138 | 146 ± 122 | 0.09 |
| Second-site diuretic | 21%± (n = 3) | 13%± (n = 3) | 0.13 |
| Admission BUN (mg/dL) | 81.8 ± 51.3 | 73.3 ± 30.9 | 0.59 |
| Admission creatinine (mg/dL) | 3.1 ± 0.8 | 3.1 ± 1.3 | 0.92 |
| Urine output prior CRRT (mL/kg/24 h) | 10.8 ± 10.2 | 7.3 ± 6.5 | 0.26 |
| Loop diuretic dose prior to CRRT (mg IV furosemide equivalent) | 141.7 ± 156.2 | 195.3 ± 165.7 | 0.15 |
| Urine/loop diuretic dose prior to CRRT (mL/kg/24 h/mg furosemide equivalent) | 0.06 ± 0.06 | 0.03 ± 0.02 | 0.15 |
| BUN prior to CRRT (mg/dL) | 98.7 ± 55.5 | 83.8 ± 26.9 | 0.36 |
| Creatinine prior to CRRT (mg/dL) | 3.8 ± 1.7 | 4.2 ± 1.3 | 0.42 |
| CRRT dose (mL/kg/h) | 33.3 ± 7.4 | 35.1 ± 10.6 | 0.65 |
CKD, chronic kidney disease; BUN, blood urea nitrogen; CRRT, continuous renal replacement therapy; IV, intravenous.